An orthotopic model of murine osteosarcoma with clonally related variants differing in pulmonary metastatic potential
Abstract
To provide an investigative tool for the study of osteosarcoma (OSA) biology we have developed a syngeneic (balb/c) murine model of OSA, using cell lines derived from a spontaneously occurring murine OSA (Schmidt et al. Differentiation 1988; 39: 151-60). This model is characterized by orthotopic primary tumor growth, a period of minimal residual disease, spontaneous pulmonary metastasis, and clonally related variants (K7M2 and K12) that differ in pulmonary metastatic potential. Primary tumor and pulmonary metastasis histology was consistent with OSA in human patients. Expression of bone sialoprotein, biglyan, decorrin, and osteopontin was suggestive of bone lineage cells. The development and use of a more aggressive OSA cell line (K7M2) resulted in spontaneous metastasis to the lungs in over 90% of mice, whereas metastases were seen in only 33% of mice when a less aggressive OSA cell line (K12; Schmidt et al. Differentiation 1988; 39: 151-60) was used. Death from metastasis occurred at a median of 76 days using K7M2 whereas no median was achieved after 140 days using K12. Angiogenic potential, characterized by CD31 and factor VIII staining of primary tumors and pulmonary metastases, was greater in the K7M2 model compared to the K12 model. No significant differences in the in vitro or in vivo expression of angiogenesis associated genes (flt1, flt4, TIE1, TIE2, and VEGF) was found between K7M2 and K12. This well characterized and relevant model of OSA will be a valuable resource to improve our understanding of the biology and treatment of metastasis in OSA.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Companion cell lines with enhanced lung colonization capacity have enabled study of metastasis-driving mechanisms.
“Companion cell lines with enhanced lung colonization capacity, such as SaOS2-LM7, MG63.3 and 143B 209,210,211 , have enabled the study of metastasis-driving mechanisms 50,212 .”
From Osteosarcoma (2022) · cites this paper as [210]
Mouse-derived cultures, from spontaneous tumours or engineered models, allow researchers to examine disease biology or test treatments in mice that have a functioning immune system.
“Cultures derived from mice with spontaneous osteosarcoma 210 or from genetically engineered mouse models 100,213 are available to study disease biology or therapeutics in mice with intact immune systems.”
From Osteosarcoma (2022) · cites this paper as [210]
Cites
Endostatin: an endogenous inhibitor of angiogenesis and tumor growth
O'Reilly, M. S., Boehm, T., Shing, Y., Fukai, N., Vasios, G., Lane, W. S., Flynn, E., Birkhead, J. R., Olsen, B. R., & Folkman, J. (1997) · Cell · doi:10.1016/s0092-8674(00)81848-6 · Cited by 4,486 · see citing works
OʼReilly, M. (1994) · Cell · doi:10.1016/0092-8674(94)90200-3 · Cited by 3,344 · see citing works
Vascular Channel Formation by Human Melanoma Cells in Vivo and in Vitro: Vasculogenic Mimicry
Maniotis, A. J., Folberg, R., Hess, A. R., Seftor, E. A., Gardner, L. M. G., Pe’er, J., Trent, J. M., Meltzer, P. S., & Hendrix, M. J. C. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65173-5 · Cited by 2,049 · see citing works
The pathogenesis of cancer metastasis
Poste, G. H., & Fidler, I. J. (1980) · Nature · doi:10.1038/283139a0 · Cited by 1,739 · see citing works
Tumor angiogenesis: past, present and the near future
Kerbel, R. S. (2000) · Carcinogenesis · doi:10.1093/carcin/21.3.505 · Cited by 973 · see citing works
Grzesik, W. J., & Robey, P. G. (1994) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650090408 · Cited by 369 · see citing works
Ferracini, R., Renzo, M. F. D., Scotlandi, K., Baldini, N., Olivero, M., Lollini, P., Cremona, O., Campanacci, M., & Comoglio, P. M. (1995) · PubMed · Cited by 280 · see citing works
Modulation of the Organ Microenvironment for Treatment of Cancer Metastasis
Fidler, I. J. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.21.1588 · Cited by 240 · see citing works
Comparative Aspects of Osteosarcoma
Withrow, S. J., Powers, B. E., Straw, R. C., & Wilkins, R. M. (1991) · Clinical Orthopaedics and Related Research · doi:10.1097/00003086-199109000-00023 · Cited by 239 · see citing works
Angiogenesis Inhibitors Generated by Tumors
Folkman, J. (1995) · Molecular Medicine · doi:10.1007/bf03401559 · Cited by 214 · see citing works
Vasculogenic Mimicry: How Convincing, How Novel, and How Significant?
McDonald, D. M., Munn, L. L., & Jain, R. K. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64740-2 · Cited by 187 · see citing works
Furukawa, T., Fu, X., Kubota, T., Watanabe, M., Kitajima, M., & Hoffman, R. M. (1993) · PubMed · Cited by 166 · see citing works
Modulation of tumor cell response to chemotherapy by the organ environment
Fidler, I. J., Wilmanns, C., Staroselsky, A. N., Radinsky, R., Dong, Z., & Fan, D. (1994) · Cancer and Metastasis Reviews · doi:10.1007/bf00689637 · Cited by 166 · see citing works
Berlin, Ö., Samid, D., Donthineni-Rao, R., Akeson, W. H., Amiel, D., & Woods, V. L. (1993) · PubMed · Cited by 150 · see citing works
Bruland, Ø. S., & Pihl, A. (1997) · European Journal of Cancer · doi:10.1016/s0959-8049(97)00252-9 · Cited by 147 · see citing works
A nude mouse model of human osteosarcoma lung metastases for evaluating new therapeutic strategies
Jia, S.-F., Worth, L. L., & Kleinerman, E. S. (1999) · Clinical & Experimental Metastasis · doi:10.1023/a:1006623001465 · Cited by 146 · see citing works
Manzotti, C., Audisio, R. A., & Pratesi, G. (1993) · Clinical & Experimental Metastasis · doi:10.1007/bf00880061 · Cited by 133 · see citing works
Ran, S., Gao, B., Duffy, S. L., Watkins, L. R., Rote, N., & Thorpe, P. E. (1998) · PubMed · Cited by 128 · see citing works
Ramanujan, S., Koenig, G. C., Padera, T. P., Stoll, B. R., & Jain, R. K. (2000) · PubMed · Cited by 96 · see citing works
Inhibition of Metastatic Behavior of Murine Osteosarcoma by Hypophysectomy
Pollak, M., Sem, A., Richard, M., Tetenes, E., & Bell, R. S. (1992) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/84.12.966 · Cited by 81 · see citing works
McLemore, T. L., Eggleston, J., Shoemaker, R. H., Abbott, B. J., Bohlman, M. E., Liu, M. C., Fine, D. L., Mayo, J. G., & Boyd, M. R. (1988) · PubMed · Cited by 73 · see citing works
Identification of matrix metalloproteinases in canine neoplastic tissue
Lana, S. E., Ogilvie, G. K., Hansen, R. A., Powers, B. E., Dernell, W. S., & Withrow, S. J. (2000) · American Journal of Veterinary Research · doi:10.2460/ajvr.2000.61.111 · Cited by 68 · see citing works
Establishment and characterization of osteogenic cell lines from a spontaneous murine osteosarcoma
Schmidt, J., Strauß, G. P., Schön, A., Luz, A., Murray, A. B., Melchiori, A., Aresu, O., & Erfle, V. (1988) · Differentiation · doi:10.1111/j.1432-0436.1988.tb00090.x · Cited by 67 · see citing works
Cementum-Forming Cells Are Phenotypically Distinct from Bone-Forming Cells
Grzesik, W. J., Cheng, H., Oh, J. S., Kuznetsov, S. A., Mankani, M. H., Uzawa, K., Robey, P. G., & Yamauchi, M. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.1.52 · Cited by 66 · see citing works
Anderson, P. M., Katsanis, E., Leonard, A. S., Schow, D. A., Loeffler, C. M., Goldstein, M. B., & Ochoa, A. C. (1990) · PubMed · Cited by 63 · see citing works
In vivo selection of human renal cell carcinoma cells with high metastatic potential in nude mice
Naito, S., Walker, S. M., & Fidler, I. J. (1989) · Clinical & Experimental Metastasis · doi:10.1007/bf01753659 · Cited by 49 · see citing works
Dirix, L. Y., Vermeulen, P., Wever, I. D., & van Oosterom, A. T. (1997) · Current Opinion in Oncology · doi:10.1097/00001622-199709040-00008 · Cited by 48 · see citing works
Singh, R. K., Tsan, R. Z., & Radinsky, R. (1997) · Clinical & Experimental Metastasis · doi:10.1023/a:1018400826845 · Cited by 46 · see citing works
Timing of chemotherapy and surgery in a murine osteosarcoma model.
Bell, R. S., Roth, Y. F., Gebhardt, M. C., Bell, D. F., Rosenberg, A. E., Mankin, H. J., & Suit, H. D. (1988) · PubMed · Cited by 44 · see citing works
Host organ specifically determines cancer progression.
Togo, S., Shimada, H., Kubota, T., Moossa, A. R., & Hoffman, R. M. (1995) · PubMed · Cited by 43 · see citing works
Melbye, M., Poulsen, A.-G., Gallo, D., Pedersen, J. B., Biggar, R. J., Larsen, O., Dias, F., & Aaby, P. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980504)76:3 · Cited by 42 · see citing works
Kjønniksen, I., Winderen, M., Bruland, Ø. S., & Fodstad, Ø. (1994) · PubMed · Cited by 41 · see citing works
The Vasculature of Xenotransplanted Human Melanomas and Sarcomas on Nude Mice
Konerding, M. A., Steinberg, F., & Streffer, C. (1989) · Cells Tissues Organs · doi:10.1159/000146793 · Cited by 40 · see citing works
Crnalic, S., Håkansson, I., Boquist, L., Löfvenberg, R., & Broström, L. (1997) · Clinical & Experimental Metastasis · doi:10.1023/a:1018456911823 · Cited by 39 · see citing works
Gerstenfeld, L. C., Uporova, T. M., Schmidt, J., Strauss, P. G., Shih, S. D., Huang, L. F., Gundberg, C. M., Mizuno, S., & Glowacki, J. (1996) · PubMed · Cited by 31 · see citing works
Seitz, P. K., Zhu, B. T., & Cooper, C. W. (1992) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650070510 · Cited by 28 · see citing works
Anderson, P. M., Meyers, D. E., Hasz, D. E., Covalcuic, K., Saltzman, D. A., Khanna, C., & Uckun, F. M. (1995) · PubMed · Cited by 24 · see citing works
Self-citationDiverse roles of insulin-like growth factors in pediatric solid tumors.
Hirschfeld, S., & Helman, L. J. (1994) · PubMed · Cited by 20 · see citing works
Self-citationDirix, L. Y., & van Oosterom, A. T. (1999) · Current Opinion in Oncology · doi:10.1097/00001622-199907000-00008 · Cited by 18 · see citing works
Evaluation of in vitro chemosensitivity using human lung cancer cell lines
Kratzke, R. A., & Kramer, B. S. (1996) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240630511 · Cited by 17 · see citing works
Hiramoto, R. N., Ghanta, V. K., & Lilly, M. B. (1984) · PubMed · Cited by 17 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis
Khanna, C., Wan, X., Bose, S., Cassaday, R., Olomu, O., Mendoza, A., Yeung, C., Gorlick, R., Hewitt, S. M., & Helman, L. J. (2004) · Nature Medicine · doi:10.1038/nm982 · Cited by 705 · see citing works
Self-citationBeird, H. C., Bielack, S. S., Flanagan, A. M., Gill, J., Heymann, D., Janeway, K. A., Livingston, J. A., Roberts, R. D., Strauss, S. J., & Gorlick, R. (2022) · Nature Reviews Disease Primers · doi:10.1038/s41572-022-00409-y · Cited by 660 · see citing works
Sarcoma Derived from Cultured Mesenchymal Stem Cells
Tolar, J., Nauta, A. J., Osborn, M. J., Mortari, A., McElmurry, R. T., Bell, S., Xia, L., Zhou, N., Riddle, M. J., Schroeder, T. M., et al. (2006) · Stem Cells · doi:10.1634/stemcells.2005-0620 · Cited by 639 · see citing works
Tatum, J. L. (2006) · International Journal of Radiation Biology · doi:10.1080/09553000601002324 · Cited by 620 · see citing works
Yu, Y., Khan, J. I., Khanna, C., Helman, L. J., Meltzer, P. S., & Merlino, G. T. (2004) · Nature Medicine · doi:10.1038/nm966 · Cited by 525 · see citing works
Self-citationGermline and somatic genetics of osteosarcoma — connecting aetiology, biology and therapy
Gianferante, D. M., Mirabello, L. J., & Savage, S. A. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.16 · Cited by 470 · see citing works
Khanna, C. (2004) · Carcinogenesis · doi:10.1093/carcin/bgh261 · Cited by 466 · see citing works
Self-citationOsteosarcoma Development and Stem Cell Differentiation
Tang, N., Song, W., Luo, J., Haydon, R. C., & He, T. (2008) · Clinical Orthopaedics and Related Research · doi:10.1007/s11999-008-0335-z · Cited by 355 · see citing works
Metastasis-associated differences in gene expression in a murine model of osteosarcoma.
Khanna, C., Khan, J. I., Nguyen, P., Prehn, J., Caylor, J., Yeung, C. L., Trepel, J. B., Meltzer, P. S., & Helman, L. J. (2001) · PubMed · Cited by 282 · see citing works
Self-citationMolecular Pathogenesis of Osteosarcoma
Kansara, M., & Thomas, D. M. (2007) · DNA and Cell Biology · doi:10.1089/dna.2006.0505 · Cited by 273 · see citing works
Adhikari, A. S., Agarwal, N. A., Wood, B. M., Porretta, C. P., Ruiz, B. A., Pochampally, R. R., & Iwakuma, T. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3463 · Cited by 261 · see citing works
Kim, S. Y., Lee, C. H., Midura, B., Yeung, C. L., Mendoza, A., Hong, S. H., Ren, L., Wong, D., Korz, W., Merzouk, A., et al. (2007) · Clinical & Experimental Metastasis · doi:10.1007/s10585-007-9133-3 · Cited by 253 · see citing works
Self-citationAn Orthotopic Model of Human Osteosarcoma Growth and Spontaneous Pulmonary Metastasis
Luu, H. H., Kang, Q., Park, J. K., Si, W., Luo, Q., Jiang, W., Yin, H. X., MONTAG, A. G., Simon, M. A., Peabody, T. D., et al. (2005) · Clinical & Experimental Metastasis · doi:10.1007/s10585-005-0365-9 · Cited by 233 · see citing works
Yan, K., Gao, J., Yang, T.-T., Ma, Q., Qiu, X., Fan, Q., & Ma, B. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033778 · Cited by 195 · see citing works
Gorlick, R. G., Anderson, P. M., Andrulis, I. L., Arndt, C., Beardsley, G. P., Bernstein, M. L., Bridge, J. A., Cheung, N. V., Dome, J. S., Ebb, D. H., et al. (2003) · PubMed · Cited by 194 · see citing works
Self-citationThe anti-tumor effect of shikonin on osteosarcoma by inducing RIP1 and RIP3 dependent necroptosis
Fu, Z., Deng, B., Liao, Y., Shan, L., Yin, F., Wang, Z., Zeng, H. M., Zuo, D., Hua, Y., & Cai, Z. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-580 · Cited by 181 · see citing works
Huang, G., Nishimoto, K., Zhou, Z., Hughes, D. P. M., & Kleinerman, E. S. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1460 · Cited by 164 · see citing works
Positively selected enhancer elements endow osteosarcoma cells with metastatic competence
Morrow, J. J., Bayles, I., Funnell, A. P. W., Miller, T. E., Saiakhova, A., Lizardo, M. M., Bartels, C. F., Kapteijn, M. Y., Hung, S., Mendoza, A., et al. (2018) · Nature Medicine · doi:10.1038/nm.4475 · Cited by 161 · see citing works
Self-citationMEK inhibition induces MYOG and remodels super-enhancers in RAS-driven rhabdomyosarcoma
Yohe, M. E., Gryder, B. E., Shern, J. F., Song, Y., Chou, H.-C., Sindiri, S., Mendoza, A., Patidar, R., Zhang, X., Guha, R., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aan4470 · Cited by 148 · see citing works
Blockade of the RhoA-JNK-c-Jun-MMP2 Cascade by Atorvastatin Reduces Osteosarcoma Cell Invasion
Fromigué, O., Hamidouche, Z., & Marie, P. J. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801436200 · Cited by 136 · see citing works
The actin-cytoskeleton linker protein ezrin is regulated during osteosarcoma metastasis by PKC
Ren, L., Hong, S., Cassavaugh, J. M., Osborne, T. S., Chou, A. J., Kim, S. Y., Gorlick, R. G., Hewitt, S. M., & Khanna, C. (2008) · Oncogene · doi:10.1038/onc.2008.437 · Cited by 131 · see citing works
Self-citationWolf-Dennen, K., Gordon, N. B., & Kleinerman, E. S. (2020) · OncoImmunology · doi:10.1080/2162402x.2020.1747677 · Cited by 124 · see citing works
Characterization of the metastatic phenotype of a panel of established osteosarcoma cells
Ren, L., Mendoza, A., Zhu, J., Briggs, J., Halsey, C., Hong, E. S., Burkett, S. S., Morrow, J. J., Lizardo, M. M., Osborne, T. S., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5177 · Cited by 119 · see citing works
Self-citationAntagonism of chemokine receptor CXCR3 inhibits osteosarcoma metastasis to lungs
Pradelli, E., Karimdjee-Soilihi, B., Michiels, J., Ricci, J., Millet, M.-A., Burel‐Vandenbos, F., Sullivan, T. J., Collins, T. L., Johnson, M. G., Medina, J. C., et al. (2009) · International Journal of Cancer · doi:10.1002/ijc.24665 · Cited by 110 · see citing works
Cao, Y., Zhou, Z., Crombrugghe, B. D., Nakashima, K., Guan, H., Duan, X., Jia, S.-F., & Kleinerman, E. S. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2128 · Cited by 109 · see citing works
Establishment and characterization of a new highly metastatic human osteosarcoma cell line
Su, Y., Luo, X., He, B., Wang, Y., Liang, C., Zuo, G., Liu, B., Bi, Y., Huang, J., Zhu, G., et al. (2009) · Clinical & Experimental Metastasis · doi:10.1007/s10585-009-9259-6 · Cited by 104 · see citing works
Glutaminase-1 (GLS1) inhibition limits metastatic progression in osteosarcoma
Ren, L., Ruiz‐Rodado, V., Dowdy, T., Huang, S., Issaq, S. H., Beck, J. A., Wang, H., Hoang, C. D., Lita, A., Larion, M., et al. (2020) · Cancer & Metabolism · doi:10.1186/s40170-020-0209-8 · Cited by 102 · see citing works
Modeling metastasis biology and therapy in real time in the mouse lung
Mendoza, A., Hong, S.-H., Osborne, T., Khan, M. A., Campbell, K., Briggs, J., Eleswarapu, A., Buquo, L., Ren, L., Hewitt, S. M., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40252 · Cited by 92 · see citing works
Self-citationChanges in cell shape are correlated with metastatic potential in murine and human osteosarcomas
Lyons, S. M., Alizadeh, E., Mannheimer, J., Schuamberg, K., Castle, J., Schroder, B., Turk, P. J., Thamm, D. H., & Prasad, A. (2016) · Biology Open · doi:10.1242/bio.013409 · Cited by 90 · see citing works
Segal, E., Pan, H., Benayoun, L., Kopečková, P., Shaked, Y., Kopeček, J., & Satchi‐Fainaro, R. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.02.059 · Cited by 91 · see citing works
Commonly used mouse models of osteosarcoma
Ek, E. T., Dass, C. R., & Choong, P. (2006) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2006.03.006 · Cited by 84 · see citing works
Ohba, T., Cole, H., Cates, J., Slosky, D., Haro, H., Ando, T., Schwartz, H. S., & Schoenecker, J. G. (2014) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2182 · Cited by 84 · see citing works
Titanium surfaces with adherent selenium nanoclusters as a novel anticancer orthopedic material
Tran, P. A., Sarin, L., Hurt, R. H., & Webster, T. J. (2009) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.32631 · Cited by 83 · see citing works
IL-6 and CXCL8 mediate osteosarcoma-lung interactions critical to metastasis
Gross, A. C., Cam, H., Phelps, D. A., Saraf, A. J., Bid, H. K., Cam, M., London, C. A., Winget, S. A., Arnold, M. A., Brandolini, L., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.99791 · Cited by 82 · see citing works
Canine and murine models of osteosarcoma
Beck, J. A., Ren, L., Huang, S., Berger, E. P., Bardales, K., Mannheimer, J., Mazcko, C. N., & LeBlanc, A. K. (2022) · Veterinary Pathology · doi:10.1177/03009858221083038 · Cited by 79 · see citing works
Research models and mesenchymal/epithelial plasticity of osteosarcoma
Yu, X., Yustein, J. T., & Xu, J. (2021) · Cell & Bioscience · doi:10.1186/s13578-021-00600-w · Cited by 77 · see citing works
Krause, U., Ryan, D. M., Clough, B. H., & Gregory, C. A. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.67 · Cited by 77 · see citing works
Mu, X., Isaac, C. E., Greco, N., Huard, J., & Weiss, K. R. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00143 · Cited by 77 · see citing works
Wnt10b induces chemotaxis of osteosarcoma and correlates with reduced survival
Chen, K., Fallen, S., Abaan, H. Ö., Hayran, M., Gonzalez, C., Wodajo, F., MacDonald, T., Toretsky, J. A., & Üren, A. (2008) · Pediatric Blood & Cancer · doi:10.1002/pbc.21595 · Cited by 74 · see citing works
A Review of the Association between Osteosarcoma Metastasis and Protein Translation
Osborne, T. S., & Khanna, C. (2012) · Journal of Comparative Pathology · doi:10.1016/j.jcpa.2011.12.007 · Cited by 73 · see citing works
Self-citationGuijarro, M. V., Ghivizzani, S. C., & Gibbs, C. P. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00189 · Cited by 73 · see citing works
Animal models of colorectal cancer with liver metastasis
Oh, B. Y., Hong, H. K., Lee, W. Y., & Cho, Y. B. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.01.048 · Cited by 71 · see citing works
Gordon, N. B., Koshkina, N. V., Jia, S.-F., Khanna, C., Mendoza, A., Worth, L. L., & Kleinerman, E. S. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0313 · Cited by 68 · see citing works
Self-citationYuan, J. J., Ossendorf, C., Szatkowski, J. P., Bronk, J. T., Maran, A., Yaszemski, M. J., Bolander, M. E., Sarkar, G., & Fuchs, B. (2009) · Cancer Investigation · doi:10.1080/07357900802491477 · Cited by 66 · see citing works
Measuring systematic changes in invasive cancer cell shape using Zernike moments
Alizadeh, E., Lyons, S. M., Castle, J., & Prasad, A. (2016) · Integrative Biology · doi:10.1039/c6ib00100a · Cited by 66 · see citing works
Attenuated Salmonella typhimurium with IL-2 Gene Reduces Pulmonary Metastases in Murine Osteosarcoma
Sorenson, B. S., Banton, K. L., Frykman, N. L., Leonard, A. S., & Saltzman, D. A. (2008) · Clinical Orthopaedics and Related Research · doi:10.1007/s11999-008-0243-2 · Cited by 64 · see citing works
Testing of new agents in childhood cancer preclinical models: meeting summary.
Houghton, P. J., Adamson, P. C., Blaney, S. M., Fine, H. A., Gorlick, R. G., Haber, M., Helman, L. J., Hirschfeld, S., Hollingshead, M. G., Israel, M. A., et al. (2002) · PubMed · Cited by 63 · see citing works
Self-citationReprogramming Cancer into Antigen-Presenting Cells as a Novel Immunotherapy
Linde, M. H., Fan, A. C., Köhnke, T., Trotman-Grant, A. C., Gurev, S. F., Phan, P., Zhao, F., Haddock, N. L., Nuno, K. A., Gars, E. J., et al. (2023) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-0502 · Cited by 60 · see citing works
Scrimieri, F., Askew, D., Corn, D. J., Eid, S. K., Bobanga, I., Bjelac, J. A., Tsao, M. L., Allen, F., Othman, Y., Wang, S.-C. G., et al. (2013) · OncoImmunology · doi:10.4161/onci.26889 · Cited by 59 · see citing works
Inhibition of Tumor Cell Motility by the Interferon-inducible GTPase MxA
Mushinski, J. F., Nguyen, P., Stevens, L. M., Khanna, C., Lee, S., Chung, E. J., Lee, M.-J., Kim, Y. S., Linehan, W. M., Horisberger, M. A., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m806324200 · Cited by 58 · see citing works
Self-citationAutocrine VEGF/VEGFR1 Signaling in a Subpopulation of Cells Associates with Aggressive Osteosarcoma
Ohba, T., Cates, J., Cole, H., Slosky, D., Haro, H., Ando, T., Schwartz, H. S., & Schoenecker, J. G. (2014) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-14-0037 · Cited by 58 · see citing works
Terabe, M., Khanna, C., Bose, S., Melchionda, F., Mendoza, A., Mackall, C. L., Helman, L. J., & Berzofsky, J. A. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3421 · Cited by 57 · see citing works
Self-citationOncolytic Semliki Forest Virus Vector as a Novel Candidate against Unresectable Osteosarcoma
Ketola, A., Hinkkanen, A., Yongabi, F. N., Furu, P. T., Määttä, A., Liimatainen, T., Pirinen, R. T., Björn, M. H., Hakkarainen, T., Mäkinen, K., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0251 · Cited by 52 · see citing works
Ezrin Inhibition Up-regulates Stress Response Gene Expression
Çelik, H., Bulut, G., Han, J. J., Graham, G. T., Minas, T. Z., Conn, E. J., Hong, S.-H., Pauly, G. T., Hayran, M., Li, X., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.718189 · Cited by 52 · see citing works
Mu, X., Isaac, C. E., Schott, T., Huard, J., & Weiss, K. R. (2013) · Sarcoma · doi:10.1155/2013/480713 · Cited by 50 · see citing works
Ren, L., Hong, S.-H., Chen, Q.-R., Briggs, J., Cassavaugh, J., Srinivasan, S., Lizardo, M. M., Mendoza, A., Xia, A. Y., Avadhani, N., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-0210 · Cited by 50 · see citing works
Self-citationLeaner, V. D., Chick, J. F. B., Donninger, H., Linniola, I., Mendoza, A., Khanna, C., & Birrer, M. J. (2008) · American Journal Of Pathology · doi:10.2353/ajpath.2009.071006 · Cited by 50 · see citing works
Self-citationVEGF and BMP Expression in Mouse Osteosarcoma Cells
Weiss, K. R., Cooper, G. M., Jadlowiec, J. A., McGough, R. L., & Huard, J. (2006) · Clinical Orthopaedics and Related Research · doi:10.1097/01.blo.0000229333.98781.56 · Cited by 48 · see citing works
Ge, J., Yang, N., Yang, Y., Yu, H., Yang, X., Wang, Y., Wang, T., Cheng, S., Wang, Y., Han, Z., et al. (2023) · Bioactive Materials · doi:10.1016/j.bioactmat.2023.01.008 · Cited by 47 · see citing works
Dieudonné, F., Marion, A., Marie, P. J., & Modrowski, D. (2012) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1650 · Cited by 47 · see citing works
Interactions between osteopontin and vascular endothelial growth factor: Implications for cancer
Ramchandani, D., & Weber, G. F. (2015) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2015.02.003 · Cited by 47 · see citing works
Metabolomics uncovers a link between inositol metabolism and osteosarcoma metastasis
Ren, L., Hong, E. S., Mendoza, A., Issaq, S. H., Hoang, C. T., Lizardo, M. M., LeBlanc, A. K., & Khanna, C. (2017) · Oncotarget · doi:10.18632/oncotarget.15872 · Cited by 46 · see citing works
Self-citationFHL2 Silencing Reduces Wnt Signaling and Osteosarcoma Tumorigenesis In Vitro and In Vivo
Brun, J., Dieudonné, F., Marty, C., Müller, J. M., Schüle, R., Patiño‐García, A., Lecanda, F., Fromigué, O., & Marie, P. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055034 · Cited by 46 · see citing works
Pleiotropic effects of bisphosphonates on osteosarcoma
Ohba, T., Cates, J., Cole, H., Slosky, D., Haro, H., Ichikawa, J., Ando, T., Schwartz, H. S., & Schoenecker, J. G. (2014) · Bone · doi:10.1016/j.bone.2014.03.005 · Cited by 45 · see citing works
Wagner, F., Holzapfel, B. M., McGovern, J., Shafiee, A., Baldwin, J., Martine, L. C., Lahr, C. A., Wunner, F. M., Friis, T., Bas, O., et al. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.04.030 · Cited by 46 · see citing works
Goldstein, S. D., Hayashi, M., Albert, C. M., Jackson, K. W., & Loeb, D. M. (2015) · Clinical & Experimental Metastasis · doi:10.1007/s10585-015-9738-x · Cited by 45 · see citing works
Understanding the Role of Notch in Osteosarcoma
McManus, M. M., Weiss, K. R., & Hughes, D. P. M. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-04843-7_4 · Cited by 46 · see citing works
Notch Signaling Mediates Skeletal Muscle Atrophy in Cancer Cachexia Caused by Osteosarcoma
Mu, X., Agarwal, R., March, D., Rothenberg, A. C., Voigt, C., Tebbets, J. C., Huard, J., & Weiss, K. R. (2016) · Sarcoma · doi:10.1155/2016/3758162 · Cited by 43 · see citing works
Gordon, N. B., & Kleinerman, E. S. (2009) · Cancer treatment and research · doi:10.1007/978-1-4419-0284-9_29 · Cited by 43 · see citing works
Muff, R., Rath, P., Kumar, R. M. R., Husmann, K., Born, W., Baudis, M., & Fuchs, B. (2015) · PLoS ONE · doi:10.1371/journal.pone.0125611 · Cited by 41 · see citing works
Maloney, C. W., Kallis, M. P., Edelman, M. C., Tzanavaris, C., LESSER, M. L., Soffer, S. Z., Symons, M. H., & Steinberg, B. M. (2020) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-19-0903 · Cited by 41 · see citing works
Dass, C. R., Ek, E. T., & Choong, P. (2006) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-006-0157-x · Cited by 41 · see citing works
Charan, M., Dravid, P., Cam, M., Setty, B., Roberts, R. D., Houghton, P. J., & Cam, H. (2020) · Oncotarget · doi:10.18632/oncotarget.27433 · Cited by 41 · see citing works
Maloney, C. W., Edelman, M. C., Kallis, M. P., Soffer, S. Z., Symons, M. H., & Steinberg, B. M. (2018) · Clinical Orthopaedics and Related Research · doi:10.1007/s11999.0000000000000291 · Cited by 40 · see citing works
Gordon, N. B., & Kleinerman, E. S. (2010) · Journal of Aerosol Medicine and Pulmonary Drug Delivery · doi:10.1089/jamp.2009.0812 · Cited by 40 · see citing works
Chaudary, N., & Hill, R. P. (2009) · Laboratory Investigation · doi:10.1038/labinvest.2009.16 · Cited by 40 · see citing works
Muff, R., Kumar, R. M. R., Botter, S. M., Born, W., & Fuchs, B. (2012) · Sarcoma · doi:10.1155/2012/937506 · Cited by 39 · see citing works
Hollomon, M. G., Gordon, N. B., Santiago‐O’Farrill, J. M., & Kleinerman, E. S. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-500 · Cited by 39 · see citing works
Histone deacetylase inhibition prevents the growth of primary and metastatic osteosarcoma
McGuire, J., Nerlakanti, N., Lo, C. H., Tauro, M., Utset‐Ward, T. J., Reed, D. R., & Lynch, C. C. (2020) · International Journal of Cancer · doi:10.1002/ijc.33046 · Cited by 38 · see citing works
Osteocytes Serve as a Progenitor Cell of Osteosarcoma
Sottnik, J. L., Campbell, B., Mehra, R., Behbahani‐Nejad, O., Hall, C. L., & Keller, E. T. (2014) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24793 · Cited by 37 · see citing works
Chen, X., Yang, T.-T., Wang, W., Sun, H., Ma, B., Li, C., Ma, Q., Yu, Z., & Fan, Q. (2009) · Cytotechnology · doi:10.1007/s10616-009-9239-3 · Cited by 37 · see citing works
HACE1 is a potential tumor suppressor in osteosarcoma
El-Naggar, A. M., Clarkson, P. W., Negri, G. L., Turgu, B., Zhang, F., Anglesio, M. S., & Sorensen, P. H. B. (2019) · Cell Death and Disease · doi:10.1038/s41419-018-1276-4 · Cited by 37 · see citing works
Calpain‐6 is an endothelin‐1 signaling dependent protective factor in chemoresistant osteosarcoma
Marion, A., Dieudonné, F., Patiño‐García, A., Lecanda, F., Marie, P. J., & Modrowski, D. (2011) · International Journal of Cancer · doi:10.1002/ijc.26246 · Cited by 37 · see citing works
Ichikawa, J., Cole, H. A., Magnussen, R. A., Mignemi, N. A., Butler, M., Holt, G. E., O'Rear, L., Yuasa, M., Pabla, B., Haro, H., et al. (2012) · Cancer · doi:10.1002/cncr.26518 · Cited by 36 · see citing works
Osteosarcoma Models: From Cell Lines to Zebrafish
Mohseny, A. B., Hogendoorn, P. C. W., & Cleton-Jansen, A. (2012) · Sarcoma · doi:10.1155/2012/417271 · Cited by 36 · see citing works
Sampson, V. B., Kamara, D. F., & Kolb, E. A. (2013) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2013.817988 · Cited by 35 · see citing works
p27 Is a Candidate Prognostic Biomarker and Metastatic Promoter in Osteosarcoma
Li, Y., Nakka, M., Kelly, A. J., Lau, C. C., Krailo, M., Barkauskas, D. A., Hicks, J. M., & Man, T. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-3189 · Cited by 35 · see citing works
Small-Molecule Procaspase-3 Activation Sensitizes Cancer to Treatment with Diverse Chemotherapeutics
Botham, R. C., Roth, H. S., Book, A. P., Roady, P. J., Fan, T. M., & Hergenrother, P. J. (2016) · ACS Central Science · doi:10.1021/acscentsci.6b00165 · Cited by 35 · see citing works
Immune reconstitution prevents metastatic recurrence of murine osteosarcoma
Merchant, M. S., Melchionda, F., Sinha, M. L., Khanna, C., Helman, L. J., & Mackall, C. L. (2006) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-006-0257-0 · Cited by 35 · see citing works
Self-citationProtein kinase C regulates ezrin–radixin–moesin phosphorylation in canine osteosarcoma cells
Hong, S. ‐., Osborne, T. S., Ren, L., Briggs, J., Mazcko, C. N., Burkett, S. S., & Khanna, C. (2010) · Veterinary and Comparative Oncology · doi:10.1111/j.1476-5829.2010.00249.x · Cited by 35 · see citing works
Self-citationAssessing Growth and Response to Therapy in Murine Tumor Models
Reynolds, C. P., Sun, B.-C., DeClerck, Y. A., & Moats, R. A. (2005) · Humana Press eBooks · doi:10.1385/1-59259-889-7:335 · Cited by 35 · see citing works
Cai, M., Li, X., Xu, M., Zhou, S., Fan, L., Huang, J., Xiao, C., Lee, Y., Yang, B., Wang, L., et al. (2022) · Chemical Engineering Journal · doi:10.1016/j.cej.2022.138086 · Cited by 34 · see citing works
Pulmonary Metastasectomy for Osteosarcoma: Is It Justified?
Diemel, K., Klippe, H. J., & Branscheid, D. (2009) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-540-77960-5_12 · Cited by 33 · see citing works
The Clinical Relevance of Molecular Genetics in Soft Tissue Sarcomas
Ordóñez, J. L., Osuna, D., García-Domínguez, D. J., Amaral, A. T., Otero-Motta, A. P., Mackintosh, C., Sevillano, V., Barbado, M. V., Hernández, T., & de Álava, E. (2010) · Advances in Anatomic Pathology · doi:10.1097/pap.0b013e3181d98cbf · Cited by 32 · see citing works
Notch signaling regulates osteosarcoma proliferation and migration through Erk phosphorylation
Qin, J., Wang, R., Zhao, C., Wen, J., Dong, H., Wang, S., Li, Y., Zhao, Y., Li, J.-J., Yang, Y., et al. (2019) · Tissue and Cell · doi:10.1016/j.tice.2019.07.002 · Cited by 31 · see citing works
High VEGF with Rapid Growth and Early Metastasis in a Mouse Osteosarcoma Model
Yang, S., Yu, H., Krygier, J. E., Wooley, P. H., & Mott, M. (2007) · Sarcoma · doi:10.1155/2007/95628 · Cited by 31 · see citing works
The HDAC Inhibitor Vorinostat Diminishes theIn VitroMetastatic Behavior of Osteosarcoma Cells
Mu, X., Brynien, D., & Weiss, K. R. (2015) · BioMed Research International · doi:10.1155/2015/290368 · Cited by 31 · see citing works
Targeting Inflammatory Kinase as an Adjuvant Treatment for Osteosarcomas
Noh, K.-C., Kim, K.-O., Patel, N., Staples, J. R., Minematsu, H., Nair, K., & Lee, F. Y. (2011) · Journal of Bone and Joint Surgery · doi:10.2106/jbjs.j.00302 · Cited by 30 · see citing works
Kimura, K., 中野, 哲., Park, Y.-B., Tani, M., Tsuda, H., Beppu, Y., Moriya, H., & Yokota, J. (2002) · Clinical & Experimental Metastasis · doi:10.1023/a:1020395816633 · Cited by 29 · see citing works
Aanstoos, M. E., Regan, D. P., Rose, R. J., Chubb, L. S., & Ehrhart, N. P. (2016) · Clinical Orthopaedics & Related Research · doi:10.1007/s11999-015-4362-2 · Cited by 28 · see citing works
- Authors
- Khanna, C., Prehn, J., Yeung, C., Caylor, J., Tsokos, M., & Helman, L.
- Affiliations
- National Institutes of Health (US)
- Venue
- Clinical & Experimental Metastasis
- Published
- 2000-05
- Volume
- 18
- Issue
- 3
- Pages
- 261-271
- ISSN
- 0262-0898 (ISSN-L)
- 1573-7276
- OpenAlex
- W19745091
- Cited by
- 207
- References
- 42
- Citations by year
- 2026: 7 · 2025: 9 · 2024: 9 · 2023: 4 · 2022: 4 · 2021: 4 · 2020: 15 · 2019: 6 · 2018: 9 · 2017: 4 · 2016: 11 · 2015: 8 · 2014: 14 · 2013: 15 · 2012: 11
- FWCI
- 1.46
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- Clinical & Experimental Metastasis (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Sarcoma Diagnosis and Treatment
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Veterinary Oncology Research
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Keywords
- osteosarcoma, orthotopic tumor model, syngeneic murine model, lung metastasis, tumor angiogenesis, CD31, factor VIII, vascular endothelial growth factor, bone sialoprotein, osteopontin, biglycan, decorin, metastatic potential
- MeSH terms
- Animals, Bone Neoplasms, Female, Lung Neoplasms, Mice, Inbred BALB C, Models, Biological, Osteosarcoma, Survival Analysis, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review